Recursos de colección

ORBi Open Repository and Bibliography (324.361 recursos)

In may 2007, the ULg's Administrative Board (joined in June 2007 by the FUSAGx) decided to create an institutional repository and defined a strong institutional self-archiving policy to increase the visibility, accessibility and impact of the University's publications (Board's decision). This decision led to the official launch, in November 2008, of the ORBi platform including both the Academic Bibliography and the Institutional Repository of the Wallonia-Europe University Academy.

Human health sciences => Hematology

Mostrando recursos 1 - 20 de 74

  1. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.

    Sengsayadeth, Salyka; Labopin, Myriam; Boumendil, Ariane; Finke, Jurgen; Ganser, Arnold; Stelljes, Matthias; Ehninger, Gerhard; Beelen, Dietrich; Niederwieser, Dietger; Blaise, Didier; Dreger, Peter; Mufti, Ghulam; Chevallier, Patrice; Mailhol, Audrey; Gatwood, Katie S.; Gorin, Norbert; Esteve, Jordi; Ciceri, Fabio; Baron, Frédéric; Schmid, Christoph; Giebel, Sebastian; Mohty, Mohamad; Savani, Bipin N.; Nagler, Arnon
    Peer reviewed

  2. Anti-thymocyte globulin for graft-versus-host disease prophylaxis in patients with intermediate- or high-risk acute myeloid leukaemia undergoing reduced-intensity conditioning allogeneic stem cell transplantation in first complete remission - a survey on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

    Ofran, Y.; Beohou, E.; Labopin, M.; Blaise, D.; Cornelissen, J. J.; de Groot, M. R.; Socié, G.; Huynh, A.; Maertens, J.; Baron, Frédéric; Mohty, M.; Nagler, A.
    Peer reviewed

  3. Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen.

    Baron, Frédéric; Labopin, Myriam; Ruggeri, Annalisa; Cornelissen, Jan J.; Meijer, Ellen; Sengeloev, Henrik; Niederwieser, Dietger; De Groot, Marco R.; Schouten, Harry C.; Milpied, Noel; Blaise, Didier; Savani, Bipin N.; Gluckman, Eliane; Mohty, Mohamad; Nagler, Arnon
    Peer reviewed

  4. Lessons learnt from the medical and psychosocial evaluation of childhood acute lymphoblastic leukemia (ALL) survivors enrolled in EORTC Children Leukemia Group Trials between 1971 and 1998 and future perspectives for long-term outcome research

    Piette, Caroline; de Rojas, Teresa; Suciu, Stefan; Kicinski, Michal; Bertrand, Yves; de Schaetzen, Gaetan; Gilotay, Caroline; Meulemans, Bart; Rossi, Séraphine; Röhrlich, Pierre; Benoit

  5. Schnitzler syndrome associated with hairy cell leukemia presenting with chronic urticaria and arthralgias

    Fank, H.; Caers, Jo; Marot, L.; De Montjoye, L.; Tennstedt, D.; Baeck, M.; Dekeuleneer, V.
    Peer reviewed

  6. Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation

    Fostier, K.; Caers, Jo; Meuleman, N.; Broos, K.; Corthals, J.; Thielemans, K.; Schots, R.; De Keersmaecker, B.
    Peer reviewed

  7. Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network.

    Ludwig, Heinz; Delforge, Michel; Facon, Thierry; Einsele, Hermann; Gay, Francesca; Moreau, Philippe; Avet-Loiseau, Herve; Boccadoro, Mario; Hajek, Roman; Mohty, Mohamad; Cavo, Michele; Dimopoulos, Meletios A.; San-Miguel, Jesus F.; Terpos, Evangelos; Zweegman, Sonja; Garderet, Laurent; Mateos, Maria-Victoria; Cook, Gordon; Leleu, Xavier; Goldschmidt, Hartmut; Jackson, Graham; Kaiser, Martin; Weisel, Katja; van de Donk, Niels W. C. J.; Waage, Anders; Beksac, Meral; Mellqvist, Ulf H.; Engelhardt, Monika; Caers, Jo; Driessen, Christoph; Blade, Joan; Sonneveld, Pieter
    Peer reviewed

  8. Molécules ciblant les interactions entre cellules myélomateuses et ostéoclastes

    Muller, Joséphine
    BACKGROUND Multiple myeloma (MM) is an hematological malignancy characterized by the accumulation of malignant plasma cells within the bone marrow. Osteolytic bone disease (OBD) is a major feature of myeloma, which leads to pathological fractures and hypercalcemia and affects dramatically the morbidity and mortality of patients. Bisphosphonates are the mainstay therapy of MM bone disease; though they are partially effective and related to adverse effects. Research for new therapeutic approaches are of great interest. OBJECTIVES Inhibition of the kinases SRC and MELK were evaluated as treatment of OBD. In addition, the role of galectin-1 (gal-1) in osteoclast (OCL) biology was...

  9. Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study

    Servais, Sophie; Baron, Frédéric; LECHANTEUR, Chantal; SEIDEL, Laurence; Selleslag, D.; Maertens, J.; BAUDOUX, Etienne; Zachee, P.; Van Gelder, M.; Noens, L.; Kerre, T.; Lewalle, Philippe; Schroyens, W.; ORY, Aurélie; Beguin, Yves
    Peer reviewed

  10. Richter syndrome with plasmablastic lymphoma

    LADANG, Aurélie; SIMUL, Mickael; SOMJA, Joan; FOGUENNE, Jacques; GOTHOT, André; KEUTGENS, Aurore; TASSIN, Françoise

  11. Effects of the immunomodulating peptide thymosin alpha 1 in multiple myeloma and immune reconstitution after hematopoietic stem cell transplantation in murine models.

    BINSFELD, Marilène; Hannon, Muriel; Humblet-Baron, Stéphanie; Beguin, Yves; Baron, Frédéric; CAERS, Jo

  12. Detection of RhCE phenotypic variants by serologic routine blood grouping.

    BINSFELD, Marilène; GOTHOT, André; MONFORT, Mélanie

  13. Maternal embryonic leucine zipper kinase is a novel target for proliferation associated high-risk myeloma.

    Bolomsky, Arnold; Heusschen, Roy; Schlangen, Karin; Stangelberger, Kathrin; Muller, Joséphine; Schreiner, Wolfgang; Zojer, Niklas; Caers, Jo; Ludwig, Heinz
    Peer reviewed

  14. La prise en charge du lymphome chez le patient âgé

    Bonnet, Christophe
    Peer reviewed

  15. Hematologic recovery after autologus stem cell transplantation in multiple myeloma: a single center experience of 225 patients

    SID, Sélim; Baron, Frédéric; WILLEMS, Evelyne; Caers, Jo; Bonnet, Christophe; DE PRIJCK, Bernard; LEJEUNE, Marie; HAFRAOUI, Kaoutar; Servais, Sophie; JASPERS, Aurélie; Beguin, Yves
    Peer reviewed

  16. In silico analysis of structural modifications in and around the integrin alphaIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.

    Pillois, Xavier; PETERS, Pierre; Segers, Karin; Nurden, Alan T.
    Peer reviewed

  17. Gating without a gate

    GOSSET, Christian; FOGUENNE, Jacques; SIMUL, Mickael; GOTHOT, André
    Peer reviewed

  18. Automatic clustering of cell populations characterized by immunophenotyping.

    GOSSET, Christian; FOGUENNE, Jacques; SIMUL, Mickael; KEUTGENS, Aurore; TASSIN, Françoise; GOTHOT, André

  19. Unconventional richter syndrome with plasmablastic transformation

    LADANG, Aurélie; SIMUL, Mickael; SOMJA, Joan; FOGUENNE, Jacques; GOTHOT, André; KEUTGENS, Aurore; TASSIN, Françoise
    Peer reviewed

  20. A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma.

    WITHOFS, Nadia; Cousin, Francois; DE PRIJCK, Bernard; Bonnet, Christophe; Hustinx, Roland; Gambhir, Sanjiv S.; Beguin, Yves; Caers, Jo
    Peer reviewed

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.